S&P 500
(0.80%) 5 277.51 points
Dow Jones
(1.51%) 38 686 points
Nasdaq
(-0.01%) 16 735 points
Oil
(-0.94%) $77.18
Gas
(0.35%) $2.58
Gold
(-0.79%) $2 347.70
Silver
(-3.10%) $30.56
Platinum
(0.63%) $1 044.50
USD/EUR
(-0.17%) $0.921
USD/NOK
(-0.49%) $10.49
USD/GBP
(-0.05%) $0.785
USD/RUB
(0.15%) $90.40

Realtime updates for Immuneering Corporation [IMRX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated31 May 2024 @ 16:00

0.72% $ 1.390

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):
Profile picture for Immuneering Corporation

Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to treat solid tumors...

Stats
Today's Volume 158 043
Average Volume 789 755
Market Cap 41.22M
EPS $-487.15 ( 2024-05-09 )
Next earnings date ( $-0.510 ) 2024-08-01
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.750
ATR14 $0.00700 (0.50%)
Insider Trading
Date Person Action Amount type
2024-05-21 Bookman Michael Buy 143 000 Stock Option
2024-05-21 Bookman Michael Buy 101 116 Stock Option
2024-05-21 Bookman Michael Buy 93 000 Stock Option
2024-05-21 Bookman Michael Buy 47 300 Stock Option
2024-05-21 Bookman Michael Sell 143 000 Stock Option
INSIDER POWER
2.84
Last 95 transactions
Buy: 3 396 921 | Sell: 2 416 287

Volume Correlation

Long: 0.22 (neutral)
Short: 0.03 (neutral)
Signal:(68.162) Neutral

Immuneering Corporation Correlation

10 Most Positive Correlations
CPSH0.972
PRTS0.95
RETO0.949
OFS0.949
SFIX0.946
AZ0.943
BIVI0.943
TTEC0.943
ARKO0.943
DMRC0.943
10 Most Negative Correlations
BNR-0.982
CTHR-0.953
DXPE-0.95
GIFI-0.947
MNMD-0.945
PPC-0.938
RNA-0.937
TIRX-0.934
IMPPP-0.934
WHLR-0.932

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Immuneering Corporation Correlation - Currency/Commodity

The country flag 0.35
( neutral )
The country flag -0.21
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.13
( neutral )
The country flag -0.23
( neutral )

Immuneering Corporation Financials

Annual 2023
Revenue: $0
Gross Profit: $-764 138 (0.00 %)
EPS: $-1.880
FY 2023
Revenue: $0
Gross Profit: $-764 138 (0.00 %)
EPS: $-1.880
FY 2022
Revenue: $316 952
Gross Profit: $158 830 (50.11 %)
EPS: $-1.870
FY 2021
Revenue: $2.08M
Gross Profit: $927 000 (44.57 %)
EPS: $-2.46

Financial Reports:

No articles found.

Immuneering Corporation Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Immuneering Corporation

Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to treat solid tumors. The company also has five oncology programs in the discovery stage that are designed to target components of the MAPK or mTOR pathway; and two discovery stage neuroscience programs. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts. Immuneering Corporation was a former subsidiary of Teva Pharmaceutical Industries Limited.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 1.5084328651428 seconds
Number of API calls: 2
Number of DB calls: 8